XEN-D0501

N/A

Report date: 2024/12/19 20:00:08
NME

Base Information

Drug NameXEN-D0501
Drug Alias NameXEN-D0501BAY-69-9426
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2CoughPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkIrelandUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXention Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPila PharmaXention Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2CoughPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A